El sarcoma histiocítico es un desorden de células no Langerhans extremadamente raro con
un curso clínico agresivo y limitadas opciones de tratamiento. Se presenta el caso de un …

Sarcomas are aggressive mesenchymal malignancies with robust resistance to available
chemotherapies. Recently, specific genomic aberrations have been shown to drive sarcoma …

We summarize herein the literature data about molecular targeted therapies in sarcomas
and conjunctive tissue intermediate malignancies. For each clinical setting, the level of …

Background Histiocytic sarcoma (HS) is a rare neoplasm showing morphological and
immunophenotypic features of mature tissue histiocytes. We report a patient with nodal HS …

Neben den wesentlich häufigeren Lymphomen können auch Neoplasien der dendritischen
und anderer, sog." akzessorischer" Zellen primär im Lymphknoten entstehen. Dazu gehören …

The heavy chain diseases are a group of lymphoproliferative disorders of small B cells and
plasma cells that are associated with secretion of an abnormal immunoglobulin heavy chain …

Histiocytic sarcomas are malignant tumors of tissue macrophages that comprise an
incredibly rare group of hematopoietic neoplasms. Investigation of historical diagnoses of …

Primary central nervous system lymphomas (PCNLs) and histiocytic tumors are neoplasms
that correspond to their nodal or systemic counterparts but lack an apparent systemic …

Histiocytic sarcoma (HS) is an exceptionally rare malignant neoplasm derived from dendritic
cells and histiocytes, with no available effective treatment options. Akt signaling and …

Primary central nervous system lymphoma (PCNSL) is an extranodal non-Hodgkin's
lymphoma (NHL) confined to the brain, leptomeninges, eyes, and/or spinal cord (1). The …